Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of Liver Fibrosis With Cardiovascular Diseases in the General Population
Mohammad R. Ostovaneh, Bharath Ambale‐Venkatesh, Tomoki Fuji, et al.
Circulation Cardiovascular Imaging (2018) Vol. 11, Iss. 3
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
Paul Brennan, Ahmed M. Elsharkawy, Timothy J. Kendall, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 10, pp. 679-688
Open Access | Times Cited: 50
CMR assessment of epicardial edipose tissue in relation to myocardial inflammation and fibrosis in patients with new-onset atrial arrhythmias after STEMI
Yanfei Ren, Xinjia Du, Maochen Li, et al.
BMC Cardiovascular Disorders (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 2
Genome-wide and Mendelian randomisation studies of liver MRI yield insights into the pathogenesis of steatohepatitis
Constantinos A. Parisinos, H. Wilman, E. Louise Thomas, et al.
Journal of Hepatology (2020) Vol. 73, Iss. 2, pp. 241-251
Open Access | Times Cited: 117
Non‐alcoholic fatty liver disease, liver fibrosis score and cognitive function in middle‐aged adults: The Framingham Study
Galit Weinstein, Kendra Davis‐Plourde, Jayandra J. Himali, et al.
Liver International (2019) Vol. 39, Iss. 9, pp. 1713-1721
Open Access | Times Cited: 94
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
Michelle T. Long, Xiaoyu Zhang, Hanfei Xu, et al.
Hepatology (2020) Vol. 73, Iss. 2, pp. 548-559
Open Access | Times Cited: 82
Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease
Joana Vieira Barbosa, Scott Milligan, Andrew Frick, et al.
The American Journal of Gastroenterology (2022)
Closed Access | Times Cited: 55
Association of liver fibrosis with aneurysm size and mortality risk in patients undergoing open abdominal aortic aneurysm repair
Mohamad Jamalinia, Seyed Alireza Mirhosseini, mohammad reza ranjbar, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Liver Fibrosis Associated with More Severe Motor Deficits in Early Parkinson’s Disease
Aryeh Zolin, Hwai Ooi, Manqi Zhou, et al.
Clinical Neurology and Neurosurgery (2025), pp. 108861-108861
Closed Access | Times Cited: 1
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes
Rosa Lombardi, Lorena Airaghi, Giovanni Targher, et al.
Liver International (2019) Vol. 40, Iss. 2, pp. 347-354
Closed Access | Times Cited: 72
Prognostic value of multiparametric magnetic resonance imaging, transient elastography and blood‐based fibrosis markers in patients with chronic liver disease
Arjun Jayaswal, Christina Levick, Emmanuel Selvaraj, et al.
Liver International (2020) Vol. 40, Iss. 12, pp. 3071-3082
Open Access | Times Cited: 58
Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population
Yochai Schonmann, Hanny Yeshua, Itay Bentov, et al.
Digestive and Liver Disease (2020) Vol. 53, Iss. 1, pp. 79-85
Closed Access | Times Cited: 52
Liver Fibrosis Assessed Via Noninvasive Tests is Associated With Incident Heart Failure in a General Population Cohort
Theresa Hydes, Oliver John Kennedy, Kate Glyn‐Owen, et al.
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 8, pp. 1657-1667
Open Access | Times Cited: 7
Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents
Run Yang, Changming Tan, Masoud Najafi
Inflammopharmacology (2021) Vol. 30, Iss. 1, pp. 73-89
Closed Access | Times Cited: 40
Non‐alcoholic fatty liver disease and heart failure with preserved ejection fraction: from pathophysiology to practical issues
Romain Itier, Maéva Guillaume, Jean‐Etienne Ricci, et al.
ESC Heart Failure (2021) Vol. 8, Iss. 2, pp. 789-798
Open Access | Times Cited: 37
Association between nonalcoholic fatty liver disease and atrial fibrillation and other clinical outcomes: a meta-analysis
Vikash Jaiswal, Song Peng Ang, Helen Huang, et al.
Journal of Investigative Medicine (2023) Vol. 71, Iss. 6, pp. 591-602
Closed Access | Times Cited: 14
Incident heart failure in chronic kidney disease: proteomics informs biology and risk stratification
Ruth F. Dubin, Rajat Deo, Yue Ren, et al.
European Heart Journal (2024) Vol. 45, Iss. 30, pp. 2752-2767
Open Access | Times Cited: 5
Hepatic T1 Mapping as a Novel Cardio-Hepatic Axis Imaging Biomarker Early after STEMI
Luca Bergamaschi, Dimitri Arangalage, Niccolò Maurizi, et al.
European Heart Journal - Cardiovascular Imaging (2024)
Closed Access | Times Cited: 5
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
Amedeo Lonardo, Stefano Ballestri, György Baffy, et al.
Metabolism and Target Organ Damage (2024) Vol. 4, Iss. 4
Open Access | Times Cited: 5
Multiparametric MR mapping in clinical decision-making for diffuse liver disease
Helena Thomaides‐Brears, Rita Lepe, Rajarshi Banerjee, et al.
Abdominal Radiology (2020) Vol. 45, Iss. 11, pp. 3507-3522
Open Access | Times Cited: 36
Liver Fibrosis Scoring Systems as Novel Tools for Predicting Cardiovascular Outcomes in Patients Following Elective Percutaneous Coronary Intervention
Hui‐Hui Liu, Ye‐Xuan Cao, Jing‐Lu Jin, et al.
Journal of the American Heart Association (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 32
Association between liver fibrosis and incident dementia in the UK Biobank study
Neal S. Parikh, Hooman Kamel, Cenai Zhang, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 9, pp. 2622-2630
Open Access | Times Cited: 21
Molecular imaging of fibroblast activity in pressure overload heart failure using [68 Ga]Ga-FAPI-04 PET/CT
Guokun Wang, Qinqin Yang, Shengyong Wu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 50, Iss. 2, pp. 465-474
Closed Access | Times Cited: 20
Metabolic dysfunction-associated steatotic liver disease-related hepatic fibrosis increases risk of insulin resistance, type 2 diabetes, and chronic kidney disease
Weijing Zhang, Wen Jing Song, Weiyu Chen, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 6, pp. 802-810
Open Access | Times Cited: 4
Association Between Noninvasive Liver Fibrosis Scores and Heart Failure in a General Population
Xiao Liu, H T Zhang, Cindy X. Fang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 22
Open Access | Times Cited: 4
Native T1 mapping compared to ultrasound elastography for staging and monitoring liver fibrosis: an animal study of repeatability, reproducibility, and accuracy
Jinning Li, Huanhuan Liu, Caiyuan Zhang, et al.
European Radiology (2019) Vol. 30, Iss. 1, pp. 337-345
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top